It significantly inhibited the expression of MALAT1 in LoVo cells by directly inhibiting the promoter activity of MALAT1, and it inhibited cell proliferation, invasion, and migration in a dose-dependent manner in CRC. Here, MALAT1 is linked to colorectal carcinoma.